Updated Analysis Supports Evaluation of Second-Line Fedratinib to Treat Myelofibrosis
July 24th 2019Treatment with fedratinib may lead to clinically meaningful responses among patients with myelofibrosis who were previously treated with Jakafi, according to an updated analysis of the phase 2 JAKARTA2 study.
Read More
Targeted Therapies for Advanced MCL May Improve Outcomes as Front-line Treatment
June 26th 2019Mantle cell lymphoma remains incurable, despite researchers’ best efforts. However, new treatment options show promise in the relapsed/refractory setting and may improve patient outcomes if moved to the front-line, according to Dr. Reem Karmali.
Watch
Collection of Family Cancer History Is Suboptimal, Highlighting Need for Patient Reporting
June 24th 2019In assessing the quality of family cancer history entered into electronic health records, researchers found that such reporting was suboptimal – highlighting the need to optimize online collection with a provider-free approach.
Read More
Despite Advantages, Disparities in Access to Palliative Care in Kidney Cancer Remain
June 19th 2019Although palliative care has been shown to improve survival rates among patients with metastatic renal cell carcinoma, its utilization remains low while certain barriers and disparities still exist.
Read More